... Gazyva (obinutuzumab), Rituxan (rituximab), and Arzerra (ofatumumab) are monoclonal antibodies that have been FDA-approved to fight CLL. In some cases, they are a part of initial treatment. ...
... Gazyva (obinutuzumab), Rituxan (rituximab), and Arzerra (ofatumumab) are monoclonal antibodies that have been FDA-approved to fight CLL. In some cases, they are a part of initial treatment. ...
... These include: Rituximab (Rituxan) — A very common CLL treatment that may be used alone or with chemotherapy or other targeted therapies Obinutuzumab (Gazyva) — Used as an initial CLL treatment along with other cancer medications, or alone when other treatments are ineffective Moxetumomab pasudotox (Lumoxiti) — Used in the treatment of hairy cell leukemia ...
... These include: Rituximab (Rituxan) — A very common CLL treatment that may be used alone or with chemotherapy or other targeted therapies Obinutuzumab (Gazyva) — Used as an initial CLL treatment along with other cancer medications, or alone when other treatments are ineffective Moxetumomab pasudotox (Lumoxiti) — Used in the treatment of hairy cell leukemia ...
... Some treatment options include: Targeted therapy drugs such as ibrutinib (Imbruvica), acalabrutinib (Calquence), venetoclax (Venclexta), and obinutuzumab (Gazyva), alone or in different combinations The combination treatment called FCR, which includes two chemotherapy drugs, fludarabine (Fludara) and cyclophosphamide (Cytoxan), and the targeted therapy ...
... Some treatment options include: Targeted therapy drugs such as ibrutinib (Imbruvica), acalabrutinib (Calquence), venetoclax (Venclexta), and obinutuzumab (Gazyva), alone or in different combinations The combination treatment called FCR, which includes two chemotherapy drugs, fludarabine (Fludara) and cyclophosphamide (Cytoxan), and the targeted therapy ...
... Imbruvica can be used alone or in combination with rituximab or with obinutuzumab (Gazyva), another drug that targets proteins on B cells.Imbruvica is especially useful because its side effects are more tolerable than traditional chemotherapy. ...
... Imbruvica can be used alone or in combination with rituximab or with obinutuzumab (Gazyva), another drug that targets proteins on B cells.Imbruvica is especially useful because its side effects are more tolerable than traditional chemotherapy. ...
... Monoclonal antibodies that are used to treat CLL include: Arzerra (ofatumumab) Gazyva (obinutuzumab) Rituxan (rituximab) Combining Cancer TreatmentsOften, your doctor will recommend that you use a combination of targeted therapy and chemotherapy drugs. ...
... Monoclonal antibodies that are used to treat CLL include: Arzerra (ofatumumab) Gazyva (obinutuzumab) Rituxan (rituximab) Combining Cancer TreatmentsOften, your doctor will recommend that you use a combination of targeted therapy and chemotherapy drugs. ...